Petter C. Borchgrevink

The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease

Pål Klepstad, Trude Teoline Nausthaug Rakvåg, S. Kaasa et al. · Acta Anaesthesiologica Scandinavica · 2004 · 377 citations

The Norwegian Brief Pain Inventory Questionnaire

Pål Klepstad, Jon Håvard Loge, Petter C. Borchgrevink et al. · Journal of Pain and Symptom Management · 2002 · 308 citations · Full text

Quality Of Life, Pain Syndrome, Pain Therapy +10

Associations between recreational exercise and chronic pain in the general population: Evidence from the HUNT 3 study

Tormod Landmark, Pål Romundstad, Petter C. Borchgrevink et al. · Pain · 2011 · 190 citations

Pain Therapy, Physical Activity, Pain Disorders +24

Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy

M. S. T. van Holthe, Pål Klepstad, K. Zahlsen et al. · European Journal of Clinical Pharmacology · 2002 · 133 citations

Ugt2b7 H268y, Medicine, Pharmacology +9

The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning?

Nils Inge Landrø, Egil A. Fors, Lindis L. Våpenstad et al. · Pain · 2013 · 120 citations

Pain Therapy, Pain Disorders, Neuropsychology +24